[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

December 2020 | 92 pages | ID: D62BCD0AA166EN
99Strategy

US$ 3,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

Further key aspects of the report indicate that:

Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A market segmented into
  • PST-900
  • NNI-351
  • FX-9847
  • Others
Based on the end-use, the global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A market classified into
  • Colon Cancer
  • Down Syndrome
  • Lung Cancer
  • Pancreatic Cancer
  • Others
Based on geography, the global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A market segmented into
  • North America [U.S., Canada, Mexico]
  • Europe [Germany, UK, France, Italy, Rest of Europe]
  • Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
  • South America [Brazil, Argentina, Rest of Latin America]
  • Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
  • Carna Biosciences Inc
  • Felicitex Therapeutics
  • ManRos Therapeutics
  • NeuroNascent Inc
  • Pharmasum Therapeutics AS
1 RESEARCH SCOPE

1.1 Research Product Definition
1.2 Research Segmentation
  1.2.1 Product Type
  1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology

2 GLOBAL DUAL SPECIFICITY TYROSINE PHOSPHORYLATION REGULATED KINASE 1A INDUSTRY

2.1 Summary about Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Industry
2.2 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Trends
  2.2.1 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Production & Consumption Trends
  2.2.2 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Demand Structure Trends
2.3 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Cost & Price

3 MARKET DYNAMICS

3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
  3.2.1 Drivers
  3.2.2 Restraints
  3.2.3 Opportunity
  3.2.4 Risk

4 GLOBAL MARKET SEGMENTATION

4.1 Region Segmentation (2017 to 2021f)
  4.1.1 North America (U.S., Canada and Mexico)
  4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
  4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
  4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
  4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
  4.2.1 PST-900
  4.2.2 NNI-351
  4.2.3 FX-9847
  4.2.4 Others
4.3 Consumption Segmentation (2017 to 2021f)
  4.3.1 Colon Cancer
  4.3.2 Down Syndrome
  4.3.3 Lung Cancer
  4.3.4 Pancreatic Cancer
  4.3.5 Others

5 NORTH AMERICA MARKET SEGMENT

5.1 Region Segmentation (2017 to 2021f)
  5.1.1 U.S.
  5.1.2 Canada
  5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
  5.2.1 PST-900
  5.2.2 NNI-351
  5.2.3 FX-9847
  5.2.4 Others
5.3 Consumption Segmentation (2017 to 2021f)
  5.3.1 Colon Cancer
  5.3.2 Down Syndrome
  5.3.3 Lung Cancer
  5.3.4 Pancreatic Cancer
  5.3.5 Others
5.4 Impact of COVID-19 in North America

6 EUROPE MARKET SEGMENTATION

6.1 Region Segmentation (2017 to 2021f)
  6.1.1 Germany
  6.1.2 UK
  6.1.3 France
  6.1.4 Italy
  6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
  6.2.1 PST-900
  6.2.2 NNI-351
  6.2.3 FX-9847
  6.2.4 Others
6.3 Consumption Segmentation (2017 to 2021f)
  6.3.1 Colon Cancer
  6.3.2 Down Syndrome
  6.3.3 Lung Cancer
  6.3.4 Pancreatic Cancer
  6.3.5 Others
6.4 Impact of COVID-19 in Europe

7 ASIA-PACIFIC MARKET SEGMENTATION

7.1 Region Segmentation (2017 to 2021f)
  7.1.1 China
  7.1.2 India
  7.1.3 Japan
  7.1.4 South Korea
  7.1.5 Southeast Asia
  7.1.6 Australia
  7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
  7.2.1 PST-900
  7.2.2 NNI-351
  7.2.3 FX-9847
  7.2.4 Others
7.3 Consumption Segmentation (2017 to 2021f)
  7.3.1 Colon Cancer
  7.3.2 Down Syndrome
  7.3.3 Lung Cancer
  7.3.4 Pancreatic Cancer
  7.3.5 Others
7.4 Impact of COVID-19 in Europe

8 SOUTH AMERICA MARKET SEGMENTATION

8.1 Region Segmentation (2017 to 2021f)
  8.1.1 Brazil
  8.1.2 Argentina
  8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
  8.2.1 PST-900
  8.2.2 NNI-351
  8.2.3 FX-9847
  8.2.4 Others
8.3 Consumption Segmentation (2017 to 2021f)
  8.3.1 Colon Cancer
  8.3.2 Down Syndrome
  8.3.3 Lung Cancer
  8.3.4 Pancreatic Cancer
  8.3.5 Others
8.4 Impact of COVID-19 in Europe

9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION

9.1 Region Segmentation (2017 to 2021f)
  9.1.1 GCC
  9.1.2 North Africa
  9.1.3 South Africa
  9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
  9.2.1 PST-900
  9.2.2 NNI-351
  9.2.3 FX-9847
  9.2.4 Others
9.3 Consumption Segmentation (2017 to 2021f)
  9.3.1 Colon Cancer
  9.3.2 Down Syndrome
  9.3.3 Lung Cancer
  9.3.4 Pancreatic Cancer
  9.3.5 Others
9.4 Impact of COVID-19 in Europe

10 COMPETITION OF MAJOR PLAYERS

10.1 Brief Introduction of Major Players
  10.1.1 Carna Biosciences Inc
  10.1.2 Felicitex Therapeutics
  10.1.3 ManRos Therapeutics
  10.1.4 NeuroNascent Inc
  10.1.5 Pharmasum Therapeutics AS
10.2 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Date of Major Players (2017-2020e)
  10.2.1 Carna Biosciences Inc
  10.2.2 Felicitex Therapeutics
  10.2.3 ManRos Therapeutics
  10.2.4 NeuroNascent Inc
  10.2.5 Pharmasum Therapeutics AS
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation

11 MARKET FORECAST

11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
  11.3.1 Impact of COVID-19
  11.3.2 Geopolitics Overview
  11.3.3 Economic Overview of Major Countries

12 REPORT SUMMARY STATEMENT
LIST OF TABLES
Table Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Product Type Overview
Table Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Product Type Market Share List
Table Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Product Type of Major Players
Table Brief Introduction of Carna Biosciences Inc
Table Brief Introduction of Felicitex Therapeutics
Table Brief Introduction of ManRos Therapeutics
Table Brief Introduction of NeuroNascent Inc
Table Brief Introduction of Pharmasum Therapeutics AS
Table Products & Services of Carna Biosciences Inc
Table Products & Services of Felicitex Therapeutics
Table Products & Services of ManRos Therapeutics
Table Products & Services of NeuroNascent Inc
Table Products & Services of Pharmasum Therapeutics AS
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Forecast (Million USD) by Region 2021f-2026f
Table Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Forecast (Million USD) Share by Demand 2021f-2026f
LIST OF FIGURES
Figure Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PST-900 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure NNI-351 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure FX-9847 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Colon Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Down Syndrome Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Lung Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pancreatic Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PST-900 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure NNI-351 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure FX-9847 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Colon Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Down Syndrome Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Lung Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pancreatic Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PST-900 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure NNI-351 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure FX-9847 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Colon Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Down Syndrome Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Lung Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pancreatic Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PST-900 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure NNI-351 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure FX-9847 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Colon Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Down Syndrome Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Lung Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pancreatic Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PST-900 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure NNI-351 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure FX-9847 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Colon Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Down Syndrome Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Lung Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pancreatic Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure PST-900 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure NNI-351 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure FX-9847 Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Colon Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Down Syndrome Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Lung Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Pancreatic Cancer Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Revenue (Million USD) of Carna Biosciences Inc 2017-2020e
Figure Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Revenue (Million USD) of Felicitex Therapeutics 2017-2020e
Figure Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Revenue (Million USD) of ManRos Therapeutics 2017-2020e
Figure Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Revenue (Million USD) of NeuroNascent Inc 2017-2020e
Figure Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Revenue (Million USD) of Pharmasum Therapeutics AS 2017-2020e


More Publications